• Earlier this week, Benchmark began covering International Flavors & Fragrances, highlighting the company’s plan to divest its Food Ingredients segment as a key step in reshaping the business mix.
• At the same time, substantial recent insider purchases and mixed assessments of financial strength have drawn attention to the balance of opportunity and risk in IFF’s repositioning efforts.
• We’ll now examine how Benchmark’s coverage initiation, centered on the planned Food Ingredients divestiture, may influence International Flavors & Fragrances’ investment narrative.

Find 44 companies with promising cash flow potential yet trading below their fair value.

International Flavors & Fragrances Investment Narrative Recap

To own IFF today, you need to believe the ongoing portfolio reshaping will ultimately produce a more focused, higher quality business, even as recent years have brought revenue pressure and mixed balance sheet signals. Benchmark’s new coverage, tied closely to the Food Ingredients sale, reinforces that the divestiture is the key near term catalyst, while financial strength concerns and valuation debates remain the biggest near term risks. The coverage itself does not materially change those underlying drivers.

The most relevant recent announcement is IFF’s agreement to sell its Food Ingredients business to CVC Capital Partners for about US$4.3 billion, with closing targeted by late Q2 2027. This deal sits at the heart of the current investment story: it is intended to sharpen the focus on Taste, Scent, and Health & Biosciences, support deleveraging, and potentially improve earnings quality, even as investors weigh the trade off between near term execution risk and longer term portfolio benefits.

Yet behind the insider buying and bullish coverage, investors should also be aware of the concerns around balance sheet resilience and financial distress risk...

International Flavors & Fragrances’ narrative projects $11.4 billion revenue and $784.4 million earnings by 2028. This requires a 0.3% yearly revenue decline and about a $1.18 billion earnings increase from -$393.0 million today.

Uncover how International Flavors & Fragrances' forecasts yield a $90.71 fair value, a 16% upside to its current price.

Exploring Other Perspectives

Benchmark’s upbeat take comes as the most pessimistic analysts were previously assuming only about 1.7 percent annual revenue growth and US$896.2 million of earnings by 2029, reminding you that views on IFF’s risks and rewards can differ sharply and that this new information could shift those expectations in either direction.

Explore 3 other fair value estimates on International Flavors & Fragrances - why the stock might be worth as much as 62% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your International Flavors & Fragrances research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free International Flavors & Fragrances research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate International Flavors & Fragrances' overall financial health at a glance.

Curious About Other Options?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 24 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.